These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22083202)

  • 21. [A case of recurrent pulmonary lymphoepithelioma-like carcinoma responding to treatment with CBDCA/paclitaxel combined chemotherapy].
    Abe T; Tanabe Y; Watanabe S; Fujita N; Matsumoto N; Moriyama H; Kagamu H; Yokota T; Yoshizawa H; Gejyo F
    Gan To Kagaku Ryoho; 2004 Aug; 31(8):1215-7. PubMed ID: 15332546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I/II study of paclitaxel + carboplatin for refractory or recurrent non-small cell lung cancer.
    Gemma A; Seike M; Kosaihira S; Minegishi Y; Noro R; Nara M; Hosomi Y; Okano T; Kokubo Y; Yoshimura A; Shibuya M; Kudoh S
    Anticancer Res; 2006; 26(4B):3083-7. PubMed ID: 16886638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effective combination chemotherapy using paclitaxel in the treatment of a small-cell lung cancer patient resistant to multiple drugs].
    Yoshida T; Mori K; Kamiyama Y; Tominaga K
    Gan To Kagaku Ryoho; 2001 Oct; 28(10):1437-40. PubMed ID: 11681253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized study of etoposide and carboplatin with or without paclitaxel in the treatment of small cell lung cancer.
    Birch R; Weaver CH; Hainsworth JD; Bobo C; Greco FA
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-135-S12-137. PubMed ID: 9331138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular Endothelial Growth Factor in Plasma and Pleural Effusion Is a Biomarker for Outcome After Bevacizumab plus Carboplatin-Paclitaxel Treatment for Non-small Cell Lung Cancer with Malignant Pleural Effusion.
    Tamiya M; Tamiya A; Yasue T; Nakao K; Omachi N; Shiroyama T; Tani E; Hamaguchi M; Morishita N; Suzuki H; Okamoto N; Okishio K; Kawaguchi T; Atagi S; Hirashima T
    Anticancer Res; 2016 Jun; 36(6):2939-44. PubMed ID: 27272808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A case of Clostridium difficile colitis associated with paclitaxel and carboplatin chemotherapy for lung cancer].
    Maeda Y; Yamazaki K; Kikuchi E; Harada T; Hizawa N; Nishimura M
    Nihon Kokyuki Gakkai Zasshi; 2005 Nov; 43(11):668-72. PubMed ID: 16366365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment rationale and study design for a randomized trial of pemetrexed/carboplatin followed by maintenance pemetrexed versus paclitaxel/carboplatin/bevacizumab followed by maintenance bevacizumab in patients with advanced non-small-cell lung cancer of nonsquamous histology.
    Zinner RG; Saxman SB; Peng G; Monberg MJ; Ortuzar WI
    Clin Lung Cancer; 2010 Sep; 11(5):352-7. PubMed ID: 20837462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction pemetrexed and cisplatin followed by maintenance pemetrexed versus carboplatin plus paclitaxel plus bevacizumab followed by maintenance bevacizumab: a quality of life-oriented randomized phase III study in patients with advanced non-squamous non-small-cell lung cancer (ERACLE).
    Galetta D; Pisconti S; Cinieri S; Pappagallo GL; Gebbia V; Borsellino N; Maiello E; Rinaldi A; Montrone M; Rizzo P; Marzano N; Sasso N; Febbraro A; Colucci G
    Clin Lung Cancer; 2011 Nov; 12(6):402-6. PubMed ID: 21831718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.
    Sandler A; Gray R; Perry MC; Brahmer J; Schiller JH; Dowlati A; Lilenbaum R; Johnson DH
    N Engl J Med; 2006 Dec; 355(24):2542-50. PubMed ID: 17167137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A case of intractable pneumothorax in a patient with pulmonary adenocarcinoma during bevacizumab-containing chemotherapy].
    Tamura T; Tamura S; Nasu H; Fujimoto T; Kinoshita T
    Nihon Kokyuki Gakkai Zasshi; 2011 Sep; 49(9):702-6. PubMed ID: 22073619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case of advanced clear cell carcinoma of the endometrium that responded remarkably to neoadjuvant chemotherapy of combination carboplatin plus weekly paclitaxel].
    Takami M; Ohta Y; Nakayama Y; Fukai H; Matsumoto H; Takimoto T; Sakamoto H; Yamamoto T
    Gan To Kagaku Ryoho; 2007 Mar; 34(3):457-60. PubMed ID: 17353643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical investigation of weekly Carboplatin and Paclitaxel with concurrent radiation therapy for locally advanced non-small cell lung cancer].
    Mito A; Yamasaki M; Matsuura K; Kajihara T; Nitta T; Awaya H; Arita K; Kashiwado K; Ohashi N
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1653-6. PubMed ID: 19838022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase 1b study of dulanermin (recombinant human Apo2L/TRAIL) in combination with paclitaxel, carboplatin, and bevacizumab in patients with advanced non-squamous non-small-cell lung cancer.
    Soria JC; Smit E; Khayat D; Besse B; Yang X; Hsu CP; Reese D; Wiezorek J; Blackhall F
    J Clin Oncol; 2010 Mar; 28(9):1527-33. PubMed ID: 20159815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paclitaxel by 24- or 1-hour infusion n combination with carboplatin in advanced non-small cell lung cancer: the Fox Chase Cancer Center experience.
    Langer CJ; Leighton JC; Comis RL; O'Dwyer PJ; McAleer CA; Bonjo CA; Engstrom PF; Litwin S; Johnson S; Ozols RF
    Semin Oncol; 1995 Aug; 22(4 Suppl 9):18-29. PubMed ID: 7544025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A case of metastatic choriocarcinoma responding to combination chemotherapy with paclitaxel and carboplatin].
    Shimamoto K; Inatomi S; Fujimoto H; Sumioki H
    Gan To Kagaku Ryoho; 2010 May; 37(5):943-6. PubMed ID: 20495335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A phase I/randomized phase II, non-comparative, multicenter, open label trial of CP-547,632 in combination with paclitaxel and carboplatin or paclitaxel and carboplatin alone as first-line treatment for advanced non-small cell lung cancer (NSCLC).
    Cohen RB; Langer CJ; Simon GR; Eisenberg PD; Hainsworth JD; Madajewicz S; Cosgriff TM; Pierce K; Xu H; Liau K; Healey D
    Cancer Chemother Pharmacol; 2007 Jun; 60(1):81-9. PubMed ID: 17031646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case of thymic cancer effectively treated by weekly paclitaxel combined with carboplatin].
    Kondo R; Watanabe S; Ishikawa D; Tanaka T; Ohshima Y; Asakawa K; Sakagami T; Okajima M; Miura S; Hayashi Y; Tanaka J; Kagamu H; Yoshizawa H; Narita I
    Gan To Kagaku Ryoho; 2014 Dec; 41(13):2607-9. PubMed ID: 25596057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase III trial comparing carboplatin, paclitaxel, and bexarotene with carboplatin and paclitaxel in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT II.
    Blumenschein GR; Khuri FR; von Pawel J; Gatzemeier U; Miller WH; Jotte RM; Le Treut J; Sun SL; Zhang JK; Dziewanowska ZE; Negro-Vilar A
    J Clin Oncol; 2008 Apr; 26(11):1879-85. PubMed ID: 18398153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis.
    Strauss GM; Lynch TJ; Elias AD; Jacobs C; Herbst R; Leong T; Lynch C; Kwiatkowski DJ; Carey RW; Grossbard ML; Skarin AT
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-73-S12-80. PubMed ID: 9331127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II trial of ixabepilone and carboplatin with or without bevacizumab in patients with previously untreated advanced non-small-cell lung cancer.
    Spigel DR; Anthony Greco F; Waterhouse DM; Shipley DL; Zubkus JD; Bury MJ; Webb CD; Hart LL; Gian VG; Infante JR; Burris HA; Hainsworth JD
    Lung Cancer; 2012 Oct; 78(1):70-5. PubMed ID: 22947511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.